Patents by Inventor Sachiyo Tanimoto

Sachiyo Tanimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5939427
    Abstract: A lotion comprising a tricyclic compound, typically 17-allyl-1,14-dihydroxy-12-?2-(4-hydroxy-3-methoxycyclohexyl)-1-methylviny l!-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo ?22.3.1.0.sup.4,9 !octacos-18-ene-2,3,10,16-tetraone, or a pharmaceutically acceptable salt thereof, a solubilizing and/or absorption-promoting agent, a liquid medium, and optionally an emulsifier and/or a viscosity increasing agent. The lotion is stable, excellent in absorption and has less irritation against the skin and sustained release. Also, the lotion is effective for the treatment and/or prophylaxis of inflammatory and hyperproliferative skin diseases and cutaneous manifestations of immunologically-mediated illnesses.
    Type: Grant
    Filed: January 5, 1998
    Date of Patent: August 17, 1999
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Akira Kagayama, Sachiyo Tanimoto, Saburo Murata, Takehisa Hata
  • Patent number: 5817333
    Abstract: A liposome preparation containing an immunosuppresive tricylic compound or a pharmaceutically acceptable salt thereof. Since the tricyclic compound is entrapped stably and quantitatively into the liposomes, a broad variety of drug forms and pharmaceutical preparations insuring a long duration of efficacy can be provided.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: October 6, 1998
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Akira Kagayama, Yuji Tokunaga, Atsunori Kaibara, Sachiyo Tanimoto, Takehisa Hata
  • Patent number: 5770607
    Abstract: This invention relates to an aqueous liquid composition for external use which contains a tricyclo compound of the chemical formula (I) presented here-under or a pharmaceutically acceptable salt thereof. More particularly, the invention relates to an aqueous liquid composition for external use characterized in that it contains said tricyclo compound and a water-soluble solubilizer. The composition of the invention is used in medical treatment.
    Type: Grant
    Filed: July 18, 1994
    Date of Patent: June 23, 1998
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Toshiyasu Honbo, Sachiyo Tanimoto, Hiromitsu Yoshida, Takehisa Hata, Sotoo Asakura, Yasuto Koyama, Youhei Kiyota
  • Patent number: 5601844
    Abstract: A sustained release medicinal preparation is produced by enclosing a macrocyclic compound represented by 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylviny l)-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1 .0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone or 17-ethyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylviny l]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1 .0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone, into the fine particles generally called microspheres which arc made of biodegradable polymer. This preparation, when, for example, given by injection, appreciably improves the transferance of said macrocyclic compound into the blood. Further, this is also used as an agent suitable for topical administration.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: February 11, 1997
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Akira Kagayama, Sumihisa Kimura, Saburo Murata, Sachiyo Tanimoto, Takehisa Hata